| Jane Howell-sammis Stuart, MS OTR | |
|
1855 Sketch Box Ln # 3, Estes Park, CO 80517-5440 | |
| (970) 430-8105 | |
| Not Available |
| Full Name | Jane Howell-sammis Stuart |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1855 Sketch Box Ln # 3, Estes Park, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710999677 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 3315 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jane Howell-sammis Stuart, MS OTR 1855 Sketch Box Ln # 3, Estes Park, CO 80517-5440 Ph: (970) 430-8105 | Jane Howell-sammis Stuart, MS OTR 1855 Sketch Box Ln # 3, Estes Park, CO 80517-5440 Ph: (970) 430-8105 |
News Archive
Stem cells offer great potential in biomedical engineering due to their pluripotency, which is the ability to multiply indefinitely and also to differentiate and develop into any kind of the hundreds of different cells and bodily tissues. But the precise complexity of how stem cell development is regulated throughout states of cellular change has been difficult to pinpoint until now.
Aggressive forms of breast cancer often manipulate the immune response in their favor. This manipulation is revealed in humans by the same immunological "signature" as in mice. This is shown by a study carried out by scientists from the University of Bonn together with Dutch colleagues.
Among approximately 26,000 women, receipt of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine during pregnancy was not associated with increased risk of preterm delivery or small-for-gestational-age birth or with hypertensive disorders of pregnancy, although a small increased risk of being diagnosed with chorioamnionitis (an inflammation of the membranes that surround the fetus) was observed, according to a study in the November 12 issue of JAMA.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a subsidiary of Valeant Pharmaceuticals International. The preparation is the first generic version of Sanofi Aventis' BenzaClin(R) to be approved by the U.S. Food and Drug Administration (FDA).
Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with non-obese men, and were at a greater risk for subsequently developing prostate cancer, according to researchers at Columbia University's Mailman School of Public Health.
› Verified 2 days ago
Rebecca Macintyre Greer, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1381 Hill Rd, Estes Park, CO 80517 Phone: 970-227-7475 | |
Mrs. Linda London Hanak, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1481 High Vista Dr, Estes Park, CO 80517 Phone: 970-586-9633 |